清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

FROM BENIGN TO MALIGNANT DISEASE

不确定意义的单克隆抗体病 多发性骨髓瘤 阿波贝克 无症状的 疾病 癌症 基因组不稳定性 生物 遗传学 生物信息学 医学 基因组 基因 病理 单克隆 免疫学 DNA DNA损伤 抗体 单克隆抗体
作者
Niccolò Bolli
出处
期刊:HemaSphere [Wolters Kluwer]
卷期号:6: 1-1
标识
DOI:10.1097/01.hs9.0000829492.11702.0a
摘要

It is believed that every multiple myeloma (MM) case evolves from asymptomatic conditions called monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM), even if these are not actually diagnosed before MM. MGUS is considered a pre-malignant condition and SMM an indolent cancer. However, this distinction was based on the clinical observation of their different rate of progression towards MM more than on actual biological studies. Recent next-generation sequencing (NGS) studies on MGUS/SMM show that these asymptomatic conditions share many of the driver genomic abnormalities of MM, indicating that the plasma cell clone has accumulated a notable oncogenic burden already in early clinical stages. However, one question is whether NGS can be exploited clinically to identify, among MGUS and SMM, patients at the highest risk of progression. Indeed, non-progressing MGUS/SMM show a distinct genomic spectrum of events, namely fewer hotspot gene mutations, segmental chromosomal deletions, complex rearrangements, and lower activity of the APOBEC family of DNA deaminases. Conversely, progressing MGUS/SMM show a genomic profile that is not different -on average- to the one of active MM at diagnosis, suggesting that current diagnostic criteria, mostly based on clinical and laboratory surrogates of disease burden, do not capture the actual disease biology. Also, using genomic techniques to estimate the time of acquisition of the first clonal event in the patient, it can be extrapolated that non-progressing MGUS/SMM arose closer to the day of sampling than active MM, where a decades-long subclinical evolution can be inferred. Looking at evolution of SMM into MM, two main patterns can be observed: one where the tumor does not change, implying it biologically is a MM from the start and early treatment may be beneficial; and another where the genomic composition of the tumor changes, implying the tumor was actually indolent at the time of diagnosis and treatment strategy may be aimed at eradication before the acquisition of aggressive subclones. Recent evidence suggests there is an advantage when treating SMM early, and studies are evaluating whether a more aggressive diagnosis approach -or even MGUS screening- may be beneficial for the patient. However, this will need to be paralleled by a better understanding of the biology of the tumor, and genomic prognostication may help better prognostication and treatment choices in MGUS/SMM patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
感动的夏岚完成签到,获得积分10
1秒前
psm发布了新的文献求助10
4秒前
喜悦半莲完成签到,获得积分10
13秒前
psm完成签到 ,获得积分10
15秒前
37秒前
失眠的修杰完成签到,获得积分10
43秒前
46秒前
acat完成签到 ,获得积分10
46秒前
超级无敌万能小金毛完成签到,获得积分10
46秒前
49秒前
单薄涵梅完成签到,获得积分10
1分钟前
老戎完成签到 ,获得积分10
1分钟前
爱笑的笑旋完成签到,获得积分10
1分钟前
爆米花的应助被科研通管家采纳,获得10
1分钟前
nnn关闭了nnn的文献求助
1分钟前
科研民工完成签到,获得积分10
1分钟前
Zyou完成签到,获得积分10
1分钟前
落后的雨筠完成签到,获得积分10
1分钟前
1分钟前
大意的之柔完成签到,获得积分10
2分钟前
依然灬聆听完成签到,获得积分10
2分钟前
会发光的小叶子完成签到,获得积分10
2分钟前
漂亮傲云完成签到,获得积分10
2分钟前
勤劳寒松完成签到,获得积分10
2分钟前
风趣馒头完成签到,获得积分10
2分钟前
激动的发卡完成签到,获得积分10
3分钟前
李健的应助被科研通管家采纳,获得10
3分钟前
Maestro_S的应助被科研通管家采纳,获得10
3分钟前
null的应助被科研通管家采纳,获得10
3分钟前
时尚的青易完成签到,获得积分10
3分钟前
感性的鸡完成签到,获得积分10
3分钟前
嘻嘻完成签到,获得积分10
4分钟前
英俊的青烟完成签到,获得积分10
4分钟前
marine完成签到 ,获得积分10
4分钟前
4分钟前
向连虎发布了新的文献求助10
4分钟前
4分钟前
超级诗桃完成签到,获得积分10
4分钟前
绛仙旧友完成签到,获得积分10
5分钟前
无辜的水蜜桃完成签到,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166338
求助须知:如何正确求助?哪些是违规求助? 9559484
关于积分的说明 21750435
捐赠科研通 7757131
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553469
邀请新用户注册赠送积分活动 2473812